Introduction The first glucagon-like peptide-1 receptor agonist (GLP-1) for type 2 diabetes mellitus (T2DM) was FDA-approved 25 years ago
Some pharmacies include it at no additional charge as part of their standard formulation
This post-treatment application is where the magic truly happens, as the peptide works in harmony with the skins healing cascade to accelerate collagen synthesis, reduce inflammation, and promote tissue remodeling
We prescribe FDA-approved semaglutide and tirzepatide medications (like Wegovy and Zepbound) or high-quality compounded* versions when clinically warranted
Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M , Harris D, Van Q, Walterscheid M, Kornblau SM
all authors contributed to the drafting and revision of the text